510(k) K213264
K213264 is an FDA 510(k) premarket notification submitted by Biosense Webster, Inc. for the device "CARTO 3 EP Navigation System Version 7.2". The FDA issued a decision of Substantially Equivalent on Oct 29, 2021. The device falls under product code DQK (Computer, Diagnostic, Programmable), a Class II device regulated under 21 CFR 870.1425. Biosense Webster, Inc. has 75 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 29, 2021
- Date Received
- Sep 30, 2021
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Computer, Diagnostic, Programmable
- Device Class
- Class II
- Regulation Number
- 870.1425
- Review Panel
- CV
- Submission Type
- 510(k)
Need the full FDA record for Biosense Webster, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.